Renalytix (LON: RENX) has signed a collaboration agreement with Tempus AI which will help to accelerate the adoption of the company’s kidneyintelX.dkd test to help slow kidney disease. The test is for predicting “progressive decline in kidney function in type 2 diabetes patients with diagnosed chronic kidney disease stages 1-3b”. The share price jumped 122.2% to 13p.
Content management systems provider Ingenta (LON: ING) increased interim revenues by 2% to £5.16m, while lower admin expenses mean pre-tax profit jumped from £615,000 to £1.2m. Cash improved to £3.9m at the end of June 2025. The interim dividend was raised from 1.5p/share to 1.75p/share. Managed services revenues offset lower content revenues. Management is awaiting contract decisions in the second half. A reduction in full year profit is anticipated. The share price increased 16.4% to 71p.
Cora Gold (LON: CORA) says portable X-ray fluorescence (pXRF) use on the Madina Foulbe project in Senegal has shown a clear link between mafic lithologies and gold mineralisation over a larger area of the Tambor anomaly. Tambor is associated with an Intrusion-Related Gold System (IRGS), which can be massive. The share price rose 11.1% to 10p.
Professional services provider Knights Group Holdings (LON: KGH) improved full year revenues from £150m to £162m, while pre-tax profit rose from £25.3m to £28m. Net debt was £64.8m at the end of April 2025. Total dividend was 9% ahead at 4.81p/share. Forecast 2025-26 pre-tax profit is £32.6m. The share price recovered 9.83% to 162p.
FALLERS
Branded spirits supplier Distil (LON: DIS) is raising £755,000 at 0.13p/share to meet near term cash requirements. The cash should last 12 months. Each share comes with a warrant exercisable at 0.2p each. Dr Graham Cooley is investing £100,000. The share price is one-fifth lower at 0.14p.
Litigation Capital Management (LON: LIT) has ended its investment in the class action against Gladstone Ports Corporation due to recent adverse case outcomes. The A$30.8m investment will be written off, although there could be claims against the original solicitors to offset this. The judgement of a co-investment case in the UK, where A$20.6m is invested, is expected in the next four weeks. A decision on the company’s ability to appeal another judgement is also due. The share price declined 16% to 32.75p.
ECR Minerals (LON: ECR) has confirmed extensive gold mineralisation at the Blue Mountain gold project in Australia. This highlights the increasing scale and potential of the project. The share price dipped 11.7% to 0.265p.
Mobile payments technology provider Bango (LON: BGO) increased interim revenues 5% to $25.2m. Annual recurring revenues were one-fifth higher at $15.6m. The loss was reduced from $4.2m to $3.2m. Net debt was $7.3m at the end of June 2025. Forecast underlying pre-tax profit is anticipated to decline from $2.7m to $400,000. That could be followed by a rebound in 2026. The shares lost some of last week’s gain, falling 10.6% to 105p.